Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOJAVE: DSR Infusate 2.0 in Diuretic-Resistant Heart Failure
NCT05965934Phase 2Unknown
- Sponsor
- Sequana Medical
- Start
- Jul 2023
- Primary completion
- Dec 2024
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 2 trial of icodextrin, dextrose in heart failure (HF), sponsored by Sequana Medical. Status: unknown.
02
Drugs
icodextrindextrose
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05965934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05965934.